Lylia N Kirpotina

Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Ureidopropanamides as Formyl Peptide Receptor 2 (FPR2) Agonists to Target the Resolution of Inflammation in Central Nervous System Disorders.

E. Lacivita, M. Leopoldo, Mauro Niso, 2022, Journal of medicinal chemistry.